Philip Schauer, MD

5.2K posts

Philip Schauer, MD banner
Philip Schauer, MD

Philip Schauer, MD

@PSchauerMD

Professor of Metabolic Surgery, Director Metamor Institute, Pennington Biomedical Research Center of Louisiana State University

Baton Rouge, LA Katılım Eylül 2015
896 Takip Edilen6.8K Takipçiler
Philip Schauer, MD retweetledi
Philip Schauer, MD retweetledi
Mediflix
Mediflix@MediflixTv·
A great doctor/patient relationship enables personal & intimate conversations about anything & everything. And that communication can be life changing. Timelapse | Stories from Living with Parkinson’s STREAMING on Mediflix: bit.ly/4obTTrE @abbvie #Sponsored @MichaelOkun
English
0
1
3
149
Philip Schauer, MD retweetledi
Louisiana Obesity Society
When you show up to testify to support a bill, and before you can fill out the green card, and Secretary of Health Bruce Greenstein and Medicaid Director Seth Gold beat you to the punch. One step closer to obesity medicine coverage for Medicaid patients with obesity. #SB433
Louisiana Obesity Society tweet media
English
0
1
3
727
Philip Schauer, MD retweetledi
American Board of Obesity Medicine
"I have obesity myself and have experienced the benefits of the effective treatment for it. I have developed a passion for sharing this and treating others so they can have the same experience that I have had, and they can lead healthier, happier lives. " #ObesityMedicine
American Board of Obesity Medicine tweet media
English
0
1
2
99
Philip Schauer, MD
Philip Schauer, MD@PSchauerMD·
Agree! Given that only 10-15% of people with clinical obesity get any evidence based treatment, it’s great we now have effective medical and surgical options. The next challenge is to figure out who should begin with surgery or medical treatment. Many may need both.
Neil Floch MD@NeilFlochMD

Accurate and succinct: the role of bariatric surgery is explained and must be included in the comprehensive treatment of obesity - additionally - surgery and medications do not overlap in effectiveness they are additive!

English
2
1
8
2.2K
Philip Schauer, MD retweetledi
Prof.Dr.Halil Coşkun
Prof.Dr.Halil Coşkun@drhalilcoskun·
As a bariatric surgeon, here is my clinical reality check to colleagues who think surgery is facing obsolescence. 1/ Sustainability & Compliance: Obesity is a lifelong chronic disease. Retatrutide’s impressive ~24% weight loss is strictly treatment-dependent. Expecting patients to adhere to weekly injections for 30-40 years is clinically unrealistic. Surgery offers a permanent metabolic reset. 2/ The Economic Barrier: The lifelong cost of next-gen multi-agonists is prohibitive. No healthcare system (NHS or private insurance) can financially sustain funding these high-cost medications indefinitely for millions of patients. 3/ The Inevitable Regain: Data (like the STEP-1 withdrawal trials) proves that once these medications are stopped, the metabolic brake is lifted. Rapid weight regain is nearly inevitable. Unless the drug is taken forever, the "Yo-Yo" effect returns with a vengeance. 4/ The Shadow of Long-Term Safety: We must remember Sibutramine—once a "miracle" drug, later pulled due to CV risks. While triple-agonists look promising, we lack 15-20 year safety data. Assuming zero long-term multisystemic side effects is a premature gamble. 5/ The Gold Standard: Bariatric surgery remains the most cost-effective, durable treatment for severe obesity, backed by decades of data. One day, science might completely replace surgery with a pill. But looking at the clinical and financial realities of today: That day is not today! @NeilFlochMD @PSchauerMD @ASMBS @IfsoSecretariat
English
1
5
12
9.2K
Philip Schauer, MD retweetledi
Jaime Ponce MD
Jaime Ponce MD@JaimePonceMD·
Honored to participate at SOFFCO.MM in Marseille France 🇫🇷 discussing the future of bariatric surgery in the era of new obesity therapies and combination treatments. Truly humbled to receive the prestigious SOFFCO Honorary Membership recognizing years of worldwide collaboration and leadership in metabolic & bariatric surgery. 🇫🇷 @ASMBS @TREOFoundation @IFSO_NAC @SecretariatIfso #IFSO #SOFFCO #BariatricSurgery #ObesityCare
Jaime Ponce MD tweet mediaJaime Ponce MD tweet mediaJaime Ponce MD tweet media
English
0
1
5
247
Philip Schauer, MD
Philip Schauer, MD@PSchauerMD·
What’s the evidence of clinical benefit of the robot for a 30 min procedure? And what is the additional cost? Adding cost and no benefit? Times have changed.
Vance L. Albaugh, MD, PhD, DABOM, DABS-FPMBS@metabolic_knife

@jdimick1 Sigh…poor use of resources indeed… I once had a surgeon tell me that you have to use the robot for EVERY CASE or else you will be accused of not offering your patients the “best”. That same surgeon also had been paid >$1 million by a company that makes a surgical robot.

English
2
1
7
10.3K